These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 11475134)

  • 41. The Mesenteric Fat and Intestinal Muscle Interface: Creeping Fat Influencing Stricture Formation in Crohn's Disease.
    Mao R; Kurada S; Gordon IO; Baker ME; Gandhi N; McDonald C; Coffey JC; Rieder F
    Inflamm Bowel Dis; 2019 Feb; 25(3):421-426. PubMed ID: 30346528
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Increased gelsolin expression and retarded collagen lattice contraction with smooth muscle cells from Crohn's diseased intestine.
    Ehrlich HP; Allison GM; Page MJ; Kolton WA; Graham M
    J Cell Physiol; 2000 Feb; 182(2):303-9. PubMed ID: 10623895
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Downregulation of Heat Shock Protein 72 Contributes to Fibrostenosis in Crohn's Disease.
    Kim SW; Lee JY; Lee HC; Ahn JB; Kim JH; Park IS; Cheon JH; Kim DH
    Gut Liver; 2023 Nov; 17(6):905-915. PubMed ID: 36814356
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Crohn's disease: a still tourbillon of etiopathogenetic theories and therapeutic strategies. Some implications in the field of urology].
    Alberti C
    G Chir; 2010 Mar; 31(3):124-33. PubMed ID: 20426926
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Acute intestinal obstruction as an initial presentation in Crohn's carcinoma.
    Dhar PM; Al-Buheisi BA; Cheriyen JK
    Int Surg; 1988; 73(3):167-9. PubMed ID: 3229924
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Therapeutic Targeting of Intestinal Fibrosis in Crohn's Disease.
    Santacroce G; Lenti MV; Di Sabatino A
    Cells; 2022 Jan; 11(3):. PubMed ID: 35159238
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Problems in the surgical treatment of Crohn's disease and our experience].
    Aleksandrova A; Nedin D
    Khirurgiia (Sofiia); 2004; 60(2):4-10. PubMed ID: 15704755
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The morphologic relationship of sinus and fistula formation to intestinal stenoses in children with Crohn's disease.
    Kahn E; Markowitz J; Blomquist K; Daum F
    Am J Gastroenterol; 1993 Sep; 88(9):1395-8. PubMed ID: 8362838
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Autophagy Stimulation as a Potential Strategy Against Intestinal Fibrosis.
    Cosin-Roger J; Canet F; Macias-Ceja DC; Gisbert-Ferrándiz L; Ortiz-Masiá D; Esplugues JV; Alós R; Navarro F; Barrachina MD; Calatayud S
    Cells; 2019 Sep; 8(9):. PubMed ID: 31540207
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mechanistic Insight into the Development of TNBS-Mediated Intestinal Fibrosis and Evaluating the Inhibitory Effects of Rapamycin.
    Mathur R; Alam MM; Zhao XF; Huang Y; Zhu X
    J Vis Exp; 2019 Sep; (151):. PubMed ID: 31566603
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Enteroliths causing intermittent obstruction in a patient with Crohn's disease.
    Meade P; McDonnell B; Fellows D; Holtzmuller KC; Runke L
    Am J Gastroenterol; 1991 Jan; 86(1):96-8. PubMed ID: 1986562
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Resistance to activated protein C is a risk factor for fibrostenosis in Crohn's disease.
    Novacek G; Miehsler W; Palkovits J; Reinisch W; Waldhör T; Kapiotis S; Gangl A; Vogelsang H
    World J Gastroenterol; 2006 Oct; 12(37):6026-31. PubMed ID: 17009403
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mechanism of fibrosis and stricture formation in Crohn's disease.
    Alfredsson J; Wick MJ
    Scand J Immunol; 2020 Dec; 92(6):e12990. PubMed ID: 33119150
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mechanisms of initiation and progression of intestinal fibrosis in IBD.
    Latella G; Di Gregorio J; Flati V; Rieder F; Lawrance IC
    Scand J Gastroenterol; 2015 Jan; 50(1):53-65. PubMed ID: 25523556
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Transforming growth factor beta signalling and matrix metalloproteinases in the mucosa overlying Crohn's disease strictures.
    Di Sabatino A; Jackson CL; Pickard KM; Buckley M; Rovedatti L; Leakey NA; Picariello L; Cazzola P; Monteleone G; Tonelli F; Corazza GR; MacDonald TT; Pender SL
    Gut; 2009 Jun; 58(6):777-89. PubMed ID: 19201776
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intestinal mucosa diamine oxidase activity reflects intestinal involvement in Crohn's disease.
    Thompson JS; Burnett DA; Markin RS; Vaughan WP
    Am J Gastroenterol; 1988 Jul; 83(7):756-60. PubMed ID: 3132852
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Obesity, visceral fat and Crohn's disease.
    Bertin B; Desreumaux P; Dubuquoy L
    Curr Opin Clin Nutr Metab Care; 2010 Sep; 13(5):574-80. PubMed ID: 20625283
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Increased Th17-inducing activity of CD14+ CD163 low myeloid cells in intestinal lamina propria of patients with Crohn's disease.
    Ogino T; Nishimura J; Barman S; Kayama H; Uematsu S; Okuzaki D; Osawa H; Haraguchi N; Uemura M; Hata T; Takemasa I; Mizushima T; Yamamoto H; Takeda K; Doki Y; Mori M
    Gastroenterology; 2013 Dec; 145(6):1380-91.e1. PubMed ID: 23993972
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study.
    Duijvestein M; Vos AC; Roelofs H; Wildenberg ME; Wendrich BB; Verspaget HW; Kooy-Winkelaar EM; Koning F; Zwaginga JJ; Fidder HH; Verhaar AP; Fibbe WE; van den Brink GR; Hommes DW
    Gut; 2010 Dec; 59(12):1662-9. PubMed ID: 20921206
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intestinal occlusion resulting from a small bowel adenocarcinoma as first onset of Crohn's disease in a healthy patient.
    Aurello P; Dente M; D'Angelo F; Nigri G; Cescon M; Ramacciato G
    Am Surg; 2009 Feb; 75(2):189-90. PubMed ID: 19280822
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.